Journal of International Oncology ›› 2021, Vol. 48 ›› Issue (6): 321-327.doi: 10.3760/cma.j.cn371439-20201026-00062
• Original Articles • Next Articles
Jiang Mengting1(), Wang Jiachun2, Zong Jing3
Received:
2020-10-26
Revised:
2020-11-23
Online:
2021-06-08
Published:
2021-06-24
Contact:
Jiang Mengting
E-mail:jmt_1234@163.com
Jiang Mengting, Wang Jiachun, Zong Jing. Effects of NFAT5 inhibition on proliferation, invasion, migration and apoptosis of lung adenocarcinoma cells[J]. Journal of International Oncology, 2021, 48(6): 321-327.
[1] |
Kuhn E, Morbini P, Cancellieri A, et al. Adenocarcinoma classification: patterns and prognosis[J]. Pathologica, 2018,110(1):5-11.
pmid: 30259909 |
[2] |
Remo A, Simeone I, Pancione M, et al. Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer[J]. J Transl Med, 2015,13:138. DOI: 10.1186/s12967-015-0492-2.
doi: 10.1186/s12967-015-0492-2 |
[3] |
Zhang S, Liao K, Miao Z, et al. CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5[J]. Neuro Oncol, 2019,21(10):1284-1296. DOI: 10.1093/neuonc/noz128.
doi: 10.1093/neuonc/noz128 |
[4] |
Kim DH, Kim KS, Ramakrishna S. NFAT5 promotes in vivo development of murine melanoma metastasis[J]. Biochem Biophys Res Commun, 2018,505(3):748-754. DOI: 10.1016/j.bbrc.2018.09.171.
doi: 10.1016/j.bbrc.2018.09.171 |
[5] |
Liu M, Zhou K, Huang Y, et al. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway[J]. J Exp Clin Cancer Res, 2015,34:121. DOI: 10.1186/s13046-015-0235-5.
doi: 10.1186/s13046-015-0235-5 |
[6] |
Yu M, Chen Y, Li X, et al. YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD[J]. Cell Death Dis, 2018,9(5):464. DOI: 10.1038/s41419-018-0515-z.
doi: 10.1038/s41419-018-0515-z |
[7] |
Li D, Fan S, Yu F, et al. FOXD1 promotes cell growth and metastasis by activation of vimentin in NSCLC[J]. Cell Physiol Biochem, 2018,51(6):2716-2731. DOI: 10.1159/000495962.
doi: 10.1159/000495962 |
[8] |
Vaeth M, Feske S. NFAT control of immune function: new frontiers for an abiding trooper[J]. F1000Res, 2018,7:260. DOI: 10.12688/f1000research.13426.1.
doi: 10.12688/f1000research |
[9] |
Jiang Y, He R, Jiang Y, et al. Transcription factor NFAT5 contri-butes to the glycolytic phenotype rewiring and pancreatic cancer progression via transcription of PGK1[J]. Cell Death Dis, 2019,10(12):948. DOI: 10.1038/s41419-019-2072-5.
doi: 10.1038/s41419-019-2072-5 |
[10] |
Qin X, Wang Y, Li J, et al. NFAT5 inhibits invasion and promotes apoptosis in hepatocellular carcinoma associated with osmolality[J]. Neoplasma, 2017,64(4):502-510. DOI: 10.4149/neo_2017_403.
doi: 10.4149/neo_2017_403 pmid: 28485155 |
[11] |
Meng X, Li Z, Zhou S, et al. miR-194 suppresses high glucose-induced non-small cell lung cancer cell progression by targeting NFAT5[J]. Thorac Cancer, 2019,10(5):1051-1059. DOI: 10.1111/1759-7714.13038.
doi: 10.1111/tca.2019.10.issue-5 |
[12] |
Cho HJ, Yun HJ, Yang HC, et al. Prognostic significance of nuclear factor of activated T-cells 5 expression in non-small cell lung cancer patients who underwent surgical resection[J]. J Surg Res, 2018,226:40-47. DOI: 10.1016/j.jss.2017.12.036.
doi: 10.1016/j.jss.2017.12.036 |
[13] |
Cicenas J, Zalyte E, Rimkus A, et al. JNK, p38, ERK, and SGK1 inhibitors in cancer[J]. Cancers (Basel), 2017,10(1):1. DOI: 10.3390/cancers10010001.
doi: 10.3390/cancers10010001 |
[14] |
Wang Y, Zhang X, Gao L, et al. Cortistatin exerts antiproliferation and antimigration effects in vascular smooth muscle cells stimulated by Ang Ⅱ through suppressing ERK1/2, p38MAPK, JNK and ERK5 signaling pathways[J]. Ann Transl Med, 2019,7(20):561. DOI: 10.21037/atm.2019.09.45.
doi: 10.21037/atm |
[15] | 郭雄飞, 王挺, 汤立新 . miR-29a对类风湿关节炎成纤维样滑膜细胞增殖和凋亡的影响[J]. 基础医学与临床, 2020,40(1):9-15. |
[16] | Küper C, Beck FX, Neuhofer W. NFAT5-mediated expression of S100A4 contributes to proliferation and migration of renal carcinoma cells[J]. Front Physiol, 2014,5:293. DOI: 10.3389/fphys.2014.00293. |
[1] | Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325. |
[2] | Ren Lu, Xie Xiaoli, Zhang Kun, Wang Lijuan. Effects and mechanisms of dihydroartemisinin combined with carfilzomib on the activity, proliferation, and apoptosis of multiple myeloma cells [J]. Journal of International Oncology, 2024, 51(3): 129-136. |
[3] | Zhang Keping, Zhao Yongsheng, Yang Juan, Fu Maoyong. Chlorogenic acid induces mitochondrial dysfunction in lung cancer A549 cells by inhibiting the PI3K-Akt pathway [J]. Journal of International Oncology, 2024, 51(1): 21-28. |
[4] | He Jiahui, Hu Qinyong. Comparative analysis of lung cancer incidence and mortality trends and risk factors in China and the United States based on GBD data [J]. Journal of International Oncology, 2024, 51(1): 29-36. |
[5] | Xiang Yuling, Tan Jiajie, Xiong Yuanguo, Zhao Lirong, Li Chen, Zhang Hong. Effects of Anhydroicaritin on the proliferation, migration and apoptosis of hepatocellular carcinoma cells [J]. Journal of International Oncology, 2023, 50(9): 513-519. |
[6] | Feng Dongxu, Wu Wei, Gao Pingfa, Wang Jun, Shi Lijuan, Chen Dawei, Li Wenbing, Zhang Meifeng. Effects of miR-451 on glycolysis and apoptosis of breast cancer cells by regulating Rho/ROCK1 pathway [J]. Journal of International Oncology, 2023, 50(8): 449-456. |
[7] | Wu Jiali, Zhang Jiahui, Zhang Ping, Xiao Xinyue, Li Rui, Zhang Hongyu. Mechanism of Bcl-2 BH4 selective inhibitor BDA-366 on NK/T cell lymphoma cells [J]. Journal of International Oncology, 2023, 50(7): 413-418. |
[8] | Yang Ya, Wang Huili, Liu Yan, Guo Jinfeng, Wang Chunxia, Lyu Min, Shan Changping. Effects of GCSH gene on proliferation and apoptosis of gastric cancer SNU-1 cells [J]. Journal of International Oncology, 2023, 50(5): 257-262. |
[9] | Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin. lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway [J]. Journal of International Oncology, 2023, 50(4): 202-207. |
[10] | Zuo Xiaoping, Liu Xiaochuan, Wu Xiqiang, Li Zhou, Xia Tian, Liu Guofeng. Risk factors and prediction model construction of arrhythmia in elderly patients with early lung cancer after thoracoscopic pulmonary resection [J]. Journal of International Oncology, 2023, 50(12): 711-716. |
[11] | Zhu Yi, Chen Jian. Mechanism of hydrogen sulfide in tumorigenesis and development and its donor-mediated anti-tumor effects [J]. Journal of International Oncology, 2023, 50(12): 729-733. |
[12] | Chen Yu, Xu Hua, Liu Hai, Chen Shixin. Construction of pathological classification prediction model for malignant pulmonary pure ground-glass nodule patients based on CT imaging [J]. Journal of International Oncology, 2023, 50(11): 655-660. |
[13] | Zhao Jianhao, Duan Yanchao. Research progress in the pathogenesis of extramedullary disease in multiple myeloma [J]. Journal of International Oncology, 2023, 50(1): 55-59. |
[14] | Yang Sha, Yang Xiaohua, Wang Suhua, Xue Xiaoyan, Xu Jun. Analysis of risk factors for deep vein thrombosis of lower extremity after thoracoscopic surgery for elderly lung cancer and establishment and validation of prediction model [J]. Journal of International Oncology, 2022, 49(9): 532-536. |
[15] | Chen Huangjing, Zhu Pengfei, Zhang Qing, Chen Guifang, Yang Chunlin, He Ying. Comparative study on the clinical value of contrast-enhanced ultrasound- and CT-guided percutaneous puncture biopsy in peripheral lung masses [J]. Journal of International Oncology, 2022, 49(8): 459-463. |
Viewed | ||||||||||||||||||||||||||||||||||||||||||||||||||
Full text 255
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Abstract 361
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||